NCT02830243

Brief Summary

The purpose of this clinical trial is to compare analgesic effect of sevoflurane and desflurane at equal minimum alveolar concentrations using surgical pleth index.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jul 2016

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 12, 2016

Completed
Same day until next milestone

Study Start

First participant enrolled

July 12, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 5, 2016

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 8, 2016

Completed
Last Updated

May 15, 2018

Status Verified

May 1, 2018

Enrollment Period

3 months

First QC Date

July 9, 2016

Last Update Submit

May 13, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Remifentanil consumption (µg/kg/min)

    During the intraoperative period

Secondary Outcomes (1)

  • Target effective site concentration of remifentanil (ng/ml)

    After at least 10 min of stable surgical pleth index values

Study Arms (2)

Sevoflurane

EXPERIMENTAL

Anesthesia was maintained with sevoflurane.

Drug: Sevoflurane

Desflurane

EXPERIMENTAL

Anesthesia was maintained with desflurane.

Drug: Desflurane

Interventions

End-tidal concentration of sevoflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period. The remifentanil infusion rate was adjusted using TCI pump to achieve surgical pleth index between 20 and 50.

Also known as: SEVO
Sevoflurane

End-tidal concentration of desflurane was maintained at age-corrected 1 minimum alveolar concentration throughout the study period. The remifentanil infusion rate was adjusted using TCI pump to achieve surgical pleth index between 20 and 50.

Also known as: DES
Desflurane

Eligibility Criteria

Age19 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients undergoing balanced general anesthesia using volatile anesthetics and remifentanil
  • patients with american society of anesthesiologist physical status I, II
  • patients aged 19-65 years
  • patients obtaining written informed consent

You may not qualify if:

  • patients with a history of any psychiatric or neurological disease
  • patients who had received any medication affecting the central nervous system
  • patients who had received medication affecting the sympathetic or parasympathetic nervous systems
  • patients undergoing tracheal intubation for airway management
  • pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kangbuk Samsung Hospital

Seoul, 03181, South Korea

Location

Related Publications (1)

  • Ryu KH, Kim JA, Ko DC, Lee SH, Choi WJ. Desflurane reduces intraoperative remifentanil requirements more than sevoflurane: comparison using surgical pleth index-guided analgesia. Br J Anaesth. 2018 Nov;121(5):1115-1122. doi: 10.1016/j.bja.2018.05.064. Epub 2018 Jul 4.

MeSH Terms

Interventions

SevofluraneDesflurane

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsEthyl Ethers

Study Officials

  • Kyoungho Ryu, M.D.

    Kangbuk Samsung Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical assistant professor

Study Record Dates

First Submitted

July 9, 2016

First Posted

July 12, 2016

Study Start

July 12, 2016

Primary Completion

October 5, 2016

Study Completion

October 8, 2016

Last Updated

May 15, 2018

Record last verified: 2018-05

Locations